Asploro Journal of Biomedical and Clinical Case Reports · May 2, 2026
An Arteriosclerotic Diabetic Male with Clinical Effect by Low Carbohydrate Diet (LCD) and Vildagliptin/Metformin (EquMet)
By Bando H, Iwatsuki N, Okada M et al.
The case was a 75-year-old male with hypertension, dyslipidemia, type 2 diabetes (T2D), mild cognitive impairment (MCI), and a general presence of arteriosclerosis for years. HbA1c remained stable at about 7.1–7.4%, and otherwise, no remarkable biochemical results were observed. Pulse wave velocity (PWV) showed an ankle-brachial index (ABI) of 0.96/1.12 and a cardio-ankle vascular index (CAVI) of 9.1/8.6 (right/left), respectively. CAVI values remained stable for 6 years. These results suggested the presence of generalized arteriosclerosis due to his previous diseases. He has been treated with vildagliptin/metformin (EquMet). From summer 2025, he maintained a low-carbohydrate diet (LCD) satisfactorily, and then HbA1c decreased to 6.0% in 2026.